Teczem (enalapril maleate/diltiazem malate)

Hoechst Marion Roussel

Approval Status
Approved October 1996

Treatment for

Cardiovascular / Cardiology , Diabetes / Endocrinology

Teczem has been approved for the treatment of hypertension. Teczem combines two compounds in a single tablet. Vasotec, manufactured by Merck, is the brand name for enalapril. Cardizem, manufactured by Hoechst Marion Roussel, is the brand name for diltiazem. Indicated for the initial treatment of high blood pressure, Teczem will be manufactured by Merck and marketed by Hoechst Marion Roussel.

Teczem is the first combination product of an ACE inhibitor and a non-dihydropyridine calcium channel blocker. Non-dihydropyridine calcium channel blockers are distinguished by their heart-rate lowering action in the treatment of hypertension.


Teczem (enalapril maleate/diltiazem malate) Drug Information

The Teczem (enalapril maleate/diltiazem malate) drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top